Lv1
78 积分 2025-01-21 加入
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
16小时前
待确认
Treatment outcomes by histology in REVEL: A randomized phase III trial of Ramucirumab plus docetaxel for advanced non-small cell lung cancer
16小时前
已完结
Two decades of PARP inhibitor synthetic lethality in cancer
1个月前
已完结
JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial
2个月前
已完结
The emerging safety profile of JAK inhibitors in rheumatic disease
2个月前
已完结
Diagnosis and Treatment of Acute Appendicitis
2个月前
已完结
Implementation of Treat‐to‐Target in Rheumatoid Arthritis Through a Learning Collaborative: Results of a Randomized Controlled Trial
4个月前
已完结
Psoriasis
5个月前
已完结
Efficacy and Safety of Dotinurad Versus Febuxostat for the Treatment of Gout: A Randomized, Multicenter, Double‐Blind, Phase 3 Trial in China
6个月前
已完结
Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study)
6个月前
已完结
皖公网安备34019202002308
